ITOC iTonic Holdings Ltd. logo

ITOC iTonic Holdings Ltd.

Healthcare
$0.31+3.43%ClosedMarket Cap: $2.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.99

P/S

9.56

EV/EBITDA

-0.53

DCF Value

$0.47

FCF Yield

-97.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

82.9%

Operating Margin

-831.1%

Net Margin

-790.6%

ROE

-44.2%

ROA

-47.2%

ROIC

-52.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q2 null$67.5K$-2.0M$
Q4 null$237.7K$-375.5K$
FY null$448.2K$-660.6K$
Q2 null$210.5K$-285.1K$

Trading Activity

Insider Trades

View All
Zhang Jianfeidirector, 10 percent owner, officer: Chief Executive Officer
SellTue Apr 07
Zhang Pengfeidirector:
SellMon Mar 16
Li Zhixinofficer
SellMon Mar 16

Company Info

Sector

Healthcare

Industry

Medical - Specialties

Country

CN

Exchange

Beta

3.18

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.